Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (8373)	1/19/1999 12:00:00 PM
From: Bluegreen	Respond to of 17367

George, it may take awhile before it sinks in for them that the pound of flesh total death has to be reached. Hopefully after it does sink in they will also be outraged and write Congress to CHANGE the way efficacy models are set up by the FDA and their lackeys, NOT do away with efficacy studies BUT make them more reasonable and don't let efficacy stand in the way of getting drugs to market. Let people decide for themselves! Let them along with their PRIVATE physician decide what course of therapy is best for THEM. I unlike others have more faith in the general public.

To: aknahow who wrote (8373)	1/20/1999 6:13:00 AM
From: Robert S.	Read Replies (3) \| Respond to of 17367

You asked:"I am confused about the triggering source for all this talk about total deaths being the end point in determining when to halt the P-3. Was it Xoma or Murphy? If Xoma, was it Ellen or Castello? What was said by whom and when?" Your response, George I think all of the above has answered. Where? I have read, once again, all of the posts from the last few days. There has been no direct answer to the simple question posed by opalapril above. It is amusing, George, that when it suits your needs, you can pontificate on anything and everything, real or imagined; yet, when you can't substantiate your statements, you haughtily declare that it is "time to move on to other issues."